期刊文献+

参苓白术散对慢性肾小球肾炎患者免疫功能的影响 被引量:4

Effect of Shenlingbaizhu powder on immune function in patients with chronic glomerulonephritis
原文传递
导出
摘要 目的 观察参苓白术散对慢性肾小球肾炎患者T淋巴细胞亚群CD3+、CD4+、CD4+/CD8+,免疫球蛋白IgA、IgG、IgM等免疫指标的影响.方法 将65例慢性肾小球肾炎患者随机分为观察组33例和对照组32例,对照组采用常规治疗,观察组在常规治疗的基础上加用参苓白术散.观察两组患者治疗前后血清CD3+、CD4+、CD4 +/CD8+,免疫球蛋白IgA、IgG、IgM变化情况及临床症状缓解情况.结果 观察组治疗后较对照组CD3+、CD4+、CD4+/CD8+水平及免疫球蛋白IgA、IgG水平有效升高,且观察组疗效优于对照组,差异均有统计学意义(P<0.05).结论 参苓白术散可提高慢性肾小球肾炎患者的免疫功能,减轻肾组织损伤,改善临床症状. Objective To observe the effect of Shenlingbaizhu powder on lymphocyte T subtype CD3 +,CD4 +,CD4 +/CD8 +,immunoglobulin IgA,IgG,IgM and immune parameters in patients with chronic glomerular nephritis.Methods Sixty-five patients with chronic glomerular nephritis were randomly divided into observation group (33 cases) and control group (32 cases),patients in control group were given the routine treatment,and patients in observation group were given Shenlingbaizhu powder on the basis of routine treatment.The serum CD3 +,CD4 +,CD4 +/CD8 +,immunoglobulin IgA,IgG,IgM changes and clinical symptoms in both groups before and after treatment were observed.Results Compared with the control group,the levels of CD3+,CD4+,CD4+/CD8+ (P <0.05) and immunoglobulin IgA,IgG increased in observation group (P < 0.05) after treatment,and the clinical curative effect of observation group was better than that of control group.There were statistically significant differences between the two groups (P < 0.05).Conclusions Shenlingbaizhu powder can improve the immune function in patients with chronic glomerulonephritis,reduce the renal tissue damage,and improve the clinical symptoms.
出处 《中国实用医刊》 2013年第24期14-15,共2页 Chinese Journal of Practical Medicine
关键词 参苓白术散 慢性肾小球肾炎 T淋巴细胞亚群 免疫球蛋白 Shenlingbaizhu powder Chronic glomerulonephritis T lymphocyte subsets Immunoglobulin
  • 相关文献

参考文献5

二级参考文献17

  • 1[1]Mugnaini EN,Egeland T,Spurkland A,et al.The T cell receptor repertoire of CD8+ CD28'T lymphocytes is dominated by expanded clones that persist over time[J].Clin Exp Immunol,1999,117:298
  • 2[2]Chapman A,Stewart SJ,Nepom GT,et al.CD11b+ CD28CD4+ human T cells:activation requirements and association with HLA-DR alleles
  • 3[3].J Immumol,1996,157:4771
  • 4[4]Effros RB.Loss of CD28 expression on T lymphocytes: a marker of replicative senescence[J].Der Comp Immunol,1997,21:471
  • 5[5]Posnett DN,Edinger JW,Manavalan JS,et al.Differentiation of the human CD8 T cells: implications for in vivo persistence of CD8 + CD28cytotoxic effector clones[ J ].Int Immunol,1999,11:229
  • 6[6]Kaneko H,Saito K,Hashimoto H,et al.Preferential elimination of CD28 +T cells in systemic lupus erythematosus (SLE) and the relation with activation induced apoptosis[J].Clin Exp Immunol,1996,106:218
  • 7[7]Alvarado C,Alcocer-varela J,Llorente L,et al.Effect of CD28 antibody on T cells from patients with systemic lupus erythematosus[J].J Autoimmunol,1994,7: 763
  • 8[8]Schwarz H,Valbracht J,Tuckwel J,et al.ILA,the human 4-1BB hamologue,is inducible in lymphoid and other cell lineages [ J].Blood,1995,15:1043
  • 9[9]Sica G,Chen L.Biochemical and immunological characteristics of 4- 1BB (CD137) receptor and ligand and potential applications in cancer therapy[J].Arch Immunol Ther Exp Warsz,1999,47:275
  • 10[10]Tan JT,Whitmire JK,Ahmed R,et al.4-1BB ligand,a member of the TNF family,is important for the generation of antiviral CD28 T cell responses[J].J Immunol,1999,163:4859

共引文献743

同被引文献190

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部